Literature DB >> 2976622

Role of the spleen in immunosuppression of gastric cancer: predominance of suppressor precursor and suppressor inducer T cells in the recirculating spleen cells.

T Toge1, K Kuroi, H Kuninobu, Y Yamaguchi, Y Kegoya, N Baba, T Hattori.   

Abstract

In order to analyse the role of the spleen on immunosuppression of gastric cancer, T cell phenotypes in the spleen cells (SC) were investigated by two colour fluorescence flow cytometry, with reference to their suppressor cell activity. Suppressor T cell phenotypes of CD4+2H4+ cells (suppressor/inducer T cells) and CD8+CD11+ (suppressor T cells) were distributed predominantly in SCs from patients with gastric cancer, while they were distributed scarcely in those with liver cirrhosis. Moreover, CD4+2H4+ cells and CD8+CD11+ cells were found predominantly in SCs and splenic vein lymphocytes (SVL) respectively. Among SCs, a significantly higher proportion of CD4+2H4+ cells was found in the recirculating SCs, but fewer were found in the residual SCs. Higher activity of Concanavalin-A induced suppressor cells was found in the former and that of spontaneously activated suppressor cells was found in the latter. These results suggest the suppressor precursor and suppressor/inducer T cells might distribute predominantly in the cells recirculating from the spleen, and that suppressor cells might be matured during the migration from the spleen.

Entities:  

Mesh:

Year:  1988        PMID: 2976622      PMCID: PMC1542017     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  13 in total

1.  Impaired immune response of splenectomised patients to polyvalent pneumococcal vaccine.

Authors:  S W Hosea; C G Burch; E J Brown; R A Berg; M M Frank
Journal:  Lancet       Date:  1981-04-11       Impact factor: 79.321

2.  Characterization of a phenotypically distinct subpopulation of Leu-2+ cells that suppresses T cell proliferative responses.

Authors:  A Landay; G L Gartland; L T Clement
Journal:  J Immunol       Date:  1983-12       Impact factor: 5.422

3.  Alterations in immunoglobulin synthesis by peripheral blood mononuclear cells from splenectomized patients with and without splenic regrowth.

Authors:  P A Drew; G K Kiroff; A Ferrante; R C Cohen
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

4.  Classification of lymphocytes recirculating in the spleen.

Authors:  R M Binns; R Pabst; S T Licence
Journal:  Immunology       Date:  1981-10       Impact factor: 7.397

Review 5.  Lymphocyte migration and immune responses.

Authors:  W L Ford
Journal:  Prog Allergy       Date:  1975

6.  Morphologic and phenotypic features of the subpopulation of Leu-2+ cells that suppresses B cell differentiation.

Authors:  L T Clement; C E Grossi; G L Gartland
Journal:  J Immunol       Date:  1984-11       Impact factor: 5.422

7.  Concanavalin A-induced and spontaneous suppressor cell activities in peripheral blood lymphocytes and spleen cells from gastric cancer patients.

Authors:  T Toge; S Hamamoto; E Itagaki; K Yajima; M Tanada; H Nakane; H Kohno; K Nakanishi; T Hattori
Journal:  Cancer       Date:  1983-11-01       Impact factor: 6.860

8.  Concanavalin A-activated suppressor cell activity in gastric cancer patients.

Authors:  T Toge; E Yanagawa; K Nakanishi; Y Yamada; M Niimoto; T Hattori
Journal:  Gan       Date:  1980-12

9.  Role of the spleen on immunosuppression in esophageal and gastric cancer.

Authors:  T Toge; A Kameda; H Yamada; Y Seto; K Aratani; T Fujita; T Hattori
Journal:  Jpn J Surg       Date:  1986-09

10.  Fluorescent phycobiliprotein conjugates for analyses of cells and molecules.

Authors:  V T Oi; A N Glazer; L Stryer
Journal:  J Cell Biol       Date:  1982-06       Impact factor: 10.539

View more
  2 in total

1.  The role of lymphocyte surface binding sites for wheat germ agglutinin in the negative regulation of cancer patients.

Authors:  T Toge; Y Yamaguchi; A Sawamura
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

2.  Excessive splenic volume is an unfavorable prognostic factor in patients with non-small cell lung cancer treated with chemoradiotherapy.

Authors:  Jianping Guo; Lei Wang; Xiaoyan Wang; Luo Li; Yajuan Lü; Congcong Wang; Chong Hao; Jiandong Zhang
Journal:  Medicine (Baltimore)       Date:  2020-12-04       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.